Ignite Creation Date:
2024-07-17 @ 11:16 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06487325
Status:
COMPLETED
Last Update Posted:
2024-07-05
First Post:
2024-06-26
Brief Title:
A Clinical Study of Ultrasound-derived Fat Fraction to Assess Metabolic Dysfunction-Associated Steatotic Liver Disease
Sponsor:
Ma Zhe
Organization:
Qianfoshan Hospital
Study Overview
Official Title:
Clinical Study of Ultrasound-derived Fat Fraction to Assess Metabolic Dysfunction-Associated Steatotic Liver Disease in Obese Population
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Aims To evaluate the diagnostic performance of ultrasound-derived fat fraction UDFF in assessing the degree of hepatic steatosis in an obese population with liver biopsy as reference standard
Materials and methods Obese individuals who were found to have fatty liver by B-mode ultrasound and underwent UDFF measurement along with liver biopsy results were retrospectively selected from The First Affiliated Hospital of Shandong First Medical UniversityThe inclusion criteria were as follows 1 BMI over 30 kgm² 2 diffuse fatty liver or inhomogeneous fatty liver diagnosed by conventional B-mode ultrasound 3 serologic test results were available The exclusion criteria include 1 patients who have undergone liver resection or have liver space-occupying lesions 2 pregnant women 3 patients with incomplete medical history data
Materials and methods Obese individuals who were found to have fatty liver by B-mode ultrasound and underwent UDFF measurement along with liver biopsy results were retrospectively selected from The First Affiliated Hospital of Shandong First Medical UniversityThe inclusion criteria were as follows 1 BMI over 30 kgm² 2 diffuse fatty liver or inhomogeneous fatty liver diagnosed by conventional B-mode ultrasound 3 serologic test results were available The exclusion criteria include 1 patients who have undergone liver resection or have liver space-occupying lesions 2 pregnant women 3 patients with incomplete medical history data
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None